CIK 0001367083
- Non-accelerated filer
- Smaller reporting company
Sonoma Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SNOA
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680423298
- Phone
- +1 800-759-9305
- Business address
- 5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
- Former names
- Oculus Innovative Sciences, Inc.
- 4 Grant or award Exe. VP of Research and Dev. acquired 3,404 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 4,124 shares (grant or award)
- 4 Grant or award Director acquired 1,036 shares (grant or award)
- 4 Grant or award Director acquired 895 shares (grant or award)
- 4 Grant or award Director acquired 612 shares (grant or award)
- 4 Grant or award Director acquired 754 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 750 shares at an average $7.02 ($5,268)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at an average $6.93 ($6,930)
- 4 Open-market buy Chief Strategy/Mkt Officer bought 750 shares at $6.82 ($5,115)
- 4 Open-market buy Chief Executive Officer bought 800 shares at an average $6.78 ($5,421)
- 4 Grant or award Director acquired 3,226 shares (grant or award)
- 4 Grant or award Director acquired 3,093 shares (grant or award)
- 4 Grant or award Director acquired 2,827 shares (grant or award)
- 4 Grant or award Director acquired 2,960 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 6 of 16 · 317 filings